BridgeMD
New treatment option for SARS CoV-2
Official title Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
ClinicalTrials.gov ID: NCT06775457
What this study is testing
- What it's testing
- Human Endogenous Retroviruses (HERVs) are ancient sequences that became integrated into our DNA during evolutionary processes. The significance of their presence in DNA is still being studied, but HERVs appear to be involved in the regulation of the immune response.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 18
You may be able to join if
- Pediatric patients, newly diagnosed with Kawasaki disease
- Pediatric patients, newly diagnosed with Vasculitis
- Pediatric patients, newly diagnosed with SARS-CoV-2 infection
- Pediatric patients, newly diagnosed with febrile virosis
- Pediatric patients with inflammatory diseases with systemic involvement
You likely can't join if
- None
The study team makes the final eligibility decision.
Where it's taking place
- Carpi, Modena, Italy
- Bologna, Italy
- Modena, Italy
- Roma, Italy
- Torino, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Carpi, Modena, Italy; Bologna, Italy; Modena, Italy; Roma, Italy; Torino, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.